[Image from BD]
The collaboration builds on ongoing efforts to advance the role of diagnostics in addressing the challenge of antimicrobial resistance (AMR), according to a news release. The companies will survey existing diagnostic practices to highlight benefits and gaps in diagnostic testing in AMR stewardship to improve and advocate for patient care, clinical practice and healthcare economics.
Get the full story at our sister site, Medical Design & Outsourcing.
Filed Under: Drug Discovery and Development
Tell Us What You Think!
You must be logged in to post a comment.